1. Home
  2. RYTM vs REYN Comparison

RYTM vs REYN Comparison

Compare RYTM & REYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rhythm Pharmaceuticals Inc.

RYTM

Rhythm Pharmaceuticals Inc.

HOLD

Current Price

$82.62

Market Cap

5.8B

Sector

Health Care

ML Signal

HOLD

Logo Reynolds Consumer Products Inc.

REYN

Reynolds Consumer Products Inc.

HOLD

Current Price

$20.73

Market Cap

4.9B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
RYTM
REYN
Founded
2008
1947
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Office Equipment/Supplies/Services
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
5.8B
4.9B
IPO Year
2017
2019

Fundamental Metrics

Financial Performance
Metric
RYTM
REYN
Price
$82.62
$20.73
Analyst Decision
Strong Buy
Hold
Analyst Count
14
6
Target Price
$131.14
$24.83
AVG Volume (30 Days)
505.0K
1.0M
Earning Date
05-05-2026
05-06-2026
Dividend Yield
N/A
4.47%
EPS Growth
28.34
N/A
EPS
N/A
1.43
Revenue
N/A
$3,756,000,000.00
Revenue This Year
$55.34
$1.91
Revenue Next Year
$86.06
$1.82
P/E Ratio
N/A
$14.65
Revenue Growth
N/A
N/A
52 Week Low
$55.31
$20.44
52 Week High
$122.20
$26.25

Technical Indicators

Market Signals
Indicator
RYTM
REYN
Relative Strength Index (RSI) 39.88 40.73
Support Level $74.50 $20.70
Resistance Level $90.79 $24.99
Average True Range (ATR) 3.24 0.49
MACD -0.28 -0.05
Stochastic Oscillator 23.60 14.42

Price Performance

Historical Comparison
RYTM
REYN

About RYTM Rhythm Pharmaceuticals Inc.

Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company engaged in the development and commercialization of therapies for patients with rare neuroendocrine diseases. The company is focused on advancing its melanocortin-4 receptor (MC4R) agonists, including its main asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. In addition, it has two early-stage investigational MC4R agonists in clinical development, RM-718 and bivamelagon, designed not to cause hyperpigmentation. The company is also focused on advancing potential candidates for congenital hyperinsulinism. It currently operates in two business segments: the United States, which generates maximum revenue, and International.

About REYN Reynolds Consumer Products Inc.

Reynolds Consumer Products Inc is a provider of household products. The firm is engaged in the production and sales of cooking products, waste and storage products, and tableware. It operates through four reportable segments namely, Reynolds Cooking and Baking, Hefty Waste and Storage, Hefty Tableware, and Presto Products. Reynolds Cooking and Baking segment produce branded and store brand aluminum foil, disposable aluminum pans, parchment paper, freezer paper, wax paper, butcher paper, plastic wrap, baking cups, oven bags and slow cooker liners.

Share on Social Networks: